Home / Inspections / 1091059

FDA Inspection 1091059 — Avadel Legacy Pharmaceuticals LLC

Avadel Legacy Pharmaceuticals LLC — FEI 3008832322

The FDA completed an inspection of Avadel Legacy Pharmaceuticals LLC on April 24, 2019 in Chesterfield, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 24, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Chesterfield, MO (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Facility

Other inspections at this facility

  • 1068774 (NAI Thu Oct 11 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1027967 (VAI Fri Oct 06 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 946968 (VAI Wed Sep 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 859453 (NAI Mon Dec 09 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 762688 (NAI Wed Nov 02 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources